{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.1699C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "Tyr",
            "alt": "Phe",
            "position": "1699"
          },
          "Protein Change": {
            "ref": "Tyr",
            "alt": "Phe",
            "position": "1699"
          },
          "Description in input context": "Y1699C mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0013946"
  },
  "Experiment Method": [
    {
      "Assay Method": "Enzymatic activity assay",
      "Material used": {
        "Material Source": "HEK293 cells",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1699C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "decreased GTPase activity",
          "Result Description": "GTPase activity was reduced by 40% for the Y1699C variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not mentioned in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "Not mentioned in the literature."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "Not mentioned in the literature."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "GTPase activity greater than 80% on day 7.",
        "Source": "Custom assumption"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "GTPase activity less than 60% on day 7.",
        "Source": "Custom assumption"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}